Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEST Trial for Chronic Low-Back Pain
NCT05396014Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in chronic low back pain (CLBP), sponsored by University of North Carolina at Chapel Hill. Started Sep 2022; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT05396014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05396014.